Levobetaxolol ophthalmic Side Effects
Applies to levobetaxolol ophthalmic: ophthalmic suspension
Although systemic adverse events have been only infrequently reported, levobetaxolol ophthalmic drops may be absorbed systemically and side effects similar to systemically administered beta-blockers such as severe respiratory or cardiac reactions have been experienced.[Ref]
Respiratory side effects have been related to the ability of levobetaxolol to inhibit bronchodilation, which may be important in some patients with reversible airway disease, including asthma or severe obstructive lung disease. Asthmatic attacks, bronchospasm, pulmonary distress, bronchitis, dyspnea, pharyngitis, pneumonia, rhinitis, and sinusitis have been reported.[Ref]
Endocrine side effects have included diabetes and hypothyroidism in less than 2% of patients, and thyrotoxicosis.[Ref]
Ocular side effects have included transient discomfort and pain after instillation (11%), transient blurred vision (2%), cataracts (<2%), and vitreous disorders (<2%).[Ref]
1. "Product Information. Betaxon (levobetaxolol ophthalmic)" Alza, Palo Alto, CA.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.